GlaxoSmithKline Pharmaceuticals Limited Stock NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
NSE India S.E.
07:05:08 2026-09-08 am EDT
|
5-day change | 1st Jan Change | ||
| 2,928.20 INR | -1.00% |
|
-2.27% | +18.38% |
| Aug. 03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| Aug. 03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 496B 5.23B 4.5B 4.23B 3.86B 7.21B 7.25B 50.16B 19.41B 254B 19.65B 19.22B 807B | P/E 2027 * |
42.6x | P/E 2028 * | 37x |
|---|---|---|---|---|---|
| Enterprise Value | 496B 5.23B 4.5B 4.23B 3.86B 7.21B 7.25B 50.16B 19.41B 254B 19.65B 19.22B 807B | EV / Sales 2027 * |
11.7x | EV / Sales 2028 * | 10.5x |
| Free-Float |
-
| Yield 2027 * |
1.01% | Yield 2028 * | 1.01% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| GLAXO | Delayed | |
NSE India S.E.
| GLAXO | Delayed |
Last Transcript : GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -1.00% | ||
| 1 week | -2.27% | ||
| Current month | -4.00% | ||
| 1 month | +12.64% | ||
| 3 months | +34.09% | ||
| 6 months | +16.32% | ||
| Current year | +18.38% |
| 1 week | 2,921.2 |  | 3,075 |
| 1 month | 2,576.1 | | 3,120.7 |
| Current year | 2,088.1 | | 3,120.7 |
| 1 year | 2,088.1 | | 3,120.7 |
| 3 years | 1,385.05 | | 3,515.7 |
| 5 years | 1,227 | | 3,515.7 |
| 10 years | 962.65 | | 3,515.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 2022-11-30 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 2026-03-31 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 2024-07-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 2019-03-31 |
| Director/Board Member | 59 | 2020-05-17 | |
Manu Anand
BRD | Director/Board Member | 67 | 2022-05-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.00% | -2.27% | - | - | 5.3B | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,024B | |
| -2.22% | -0.76% | +51.08% | +67.61% | 663B | |
| -2.99% | -4.31% | +18.59% | +66.94% | 453B | |
| -0.88% | +0.86% | +29.77% | +36.54% | 349B | |
| -10.89% | -14.63% | +9.27% | +26.87% | 295B | |
| -1.38% | -0.72% | -0.79% | +9.50% | 253B | |
| -10.08% | -10.26% | +40.32% | +51.55% | 236B | |
| -2.32% | -0.65% | -15.84% | -56.91% | 206B | |
| -2.88% | -2.19% | +26.54% | +92.95% | 187B | |
| Average | -3.35% | +0.01% | +23.46% | +42.97% | 407.48B | |
| Weighted average by Cap. | -2.42% | -1.04% | +32.70% | +57.27% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.57B 449M 386M 363M 331M 619M 622M 4.3B 1.66B 21.76B 1.69B 1.65B 69.24B | 47.24B 498M 428M 403M 368M 686M 690M 4.78B 1.85B 24.15B 1.87B 1.83B 76.84B |
| Net income | 11.65B 123M 106M 99.44M 90.74M 169M 170M 1.18B 456M 5.96B 462M 452M 18.96B | 13.42B 142M 122M 114M 104M 195M 196M 1.36B 525M 6.86B 531M 520M 21.82B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-08 | ₹2,928.20 | -1.00% | 50,684 |
| 26-09-07 | ₹2,957.80 | -0.01% | 155,659 |
| 26-09-04 | ₹2,958.10 | +0.70% | 48,109 |
| 26-09-03 | ₹2,937.50 | -0.42% | 56,012 |
| 26-09-02 | ₹2,949.90 | -1.54% | 59,227 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
